Managing term preeclampsia with angiogenic factors
Part of Women’s health & pregnancy clinical trials.
This study tests whether measuring certain proteins in the blood (angiogenic factors) can help doctors better manage preeclampsia in women who are 36 to 38 weeks pregnant. The goal is to see if this approach can safely delay delivery and improve outcomes for both mother and baby.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are carrying a single baby (not twins or more).
- You have preeclampsia (high blood pressure and protein in urine) that is not severe.
- Your baby's umbilical artery still has normal blood flow (forward motion) as seen on an ultrasound.
- Your pregnancy is between 36 weeks and 0 days and 38 weeks and 6 days along.
- Your due date was confirmed by an early pregnancy ultrasound or by IVF dates.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether measuring two pregnancy blood markers (sFlt1 and PlGF) and planning delivery timing can help prevent preeclampsia as you reach term. It may help reduce risk for mother and baby by guiding when to deliver based on test results.
This trial studies whether using specific blood-pressure medicines can help people with non-severe preeclampsia stay pregnant longer. It aims to improve outcomes by treating blood pressure early while monitoring you and the baby closely.
This trial tests a new medicine, CBP-4888, for pregnant women hospitalized with preeclampsia starting after 20 weeks. The goal is to see if it's safe and how it works for you and your baby, who will be followed for up to 24 months after birth.
This study looks at two ways to manage early-onset fetal growth restriction (when a baby is smaller than expected). It compares using blood tests for angiogenic factors versus feto-placental Doppler ultrasound to guide care. The goal is to find the best way to monitor and protect your baby's health.
This study is for pregnant women to check their risk of pre-eclampsia (a serious condition causing high blood pressure) using simple tests like blood work or ultrasound. It aims to help you and your doctor manage your pregnancy better.
This study looks at the placenta and the area where the baby meets the mother's body to understand preeclampsia, a serious pregnancy complication. If you are between 9 and 15 weeks pregnant with one baby and are already scheduled for a placenta test, you may be able to join.
Hear when a new Preeclampsia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.